(Q35786822)

English

Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma

scientific article published on April 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma (English)

1 reference

Europe PubMed Central

10 August 2017

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

T-cell acute lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

G A Hosler

1

1 reference

Europe PubMed Central

10 August 2017

R O Bash

2

1 reference

Europe PubMed Central

10 August 2017

X Bai

3

1 reference

Europe PubMed Central

10 August 2017

V Jain

4

1 reference

Europe PubMed Central

10 August 2017

R H Scheuermann

5

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

10 August 2017

The American Journal of Pathology

1 reference

Europe PubMed Central

10 August 2017

154

1 reference

Europe PubMed Central

10 August 2017

1023-1035

1 reference

Europe PubMed Central

10 August 2017

4

1 reference

Europe PubMed Central

10 August 2017

describes a project that uses

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC1866560/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

Assessment of minimal residual disease in patients with acute leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Synthesis of quantitation standards for nested competitive PCR for the determination of minimal residual disease in B-lineage acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Fifty years of studies of the biology and therapy of childhood leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Monitoring of residual disease in chronic myelogenous leukemia: methodological approaches and clinical aspects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Detection of chromosomal translocations in leukemia-lymphoma cells by polymerase chain reaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Implications of detection of minimal residual disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Childhood leukemias

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Detection of minimal residual disease in acute myelogenous leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Clinical significance of minimal residual disease in leukemia detected by polymerase chain reaction: is molecular remission a milestone for achieving a cure?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Techniques for detection of minimal residual disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Rearrangements of the tal-1 locus as clonal markers for T cell acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-1 gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Quantitation of targets for PCR by use of limiting dilution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

A Reappraisal of the Results of Stopping Therapy in Childhood Leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

12 July 2018

Quantitative polymerase chain reaction for human herpesvirus diagnosis and measurement of Epstein-Barr virus burden in posttransplant lymphoproliferative disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

25 September 2018

Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

25 September 2018

Rearrangement of the BCL-2 gene in follicular lymphoma. Detection by PCR in both fresh and fixed tissue samples.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

25 September 2018

Chromosomal translocations in human cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

25 September 2018

Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

25 September 2018

Extensive allelic sequence variation in the J region of the human immunoglobulin heavy chain gene locus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

25 September 2018

Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

25 September 2018

Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

25 September 2018

Measurement of Residual Leukemia during Remission in Childhood Acute Lymphoblastic Leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1866560

15 November 2018

Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965355-2

7 January 2021

Involvement of the bcl-2 gene in human follicular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965355-2

7 January 2021

Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965355-2

7 January 2021

Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965355-2

7 January 2021

Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965355-2

7 January 2021

Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965355-2

7 January 2021

Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965355-2

7 January 2021

Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) in a patient before and after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965355-2

7 January 2021

Polymerase chain reaction-based mRNA quantification using an internal standard: analysis of oncogene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965355-2

7 January 2021

BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2965355-2

7 January 2021

Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/10233841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10233841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10233841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/10233841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/10233841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10233841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid achievement of PML-RAR alpha polymerase chain reaction (PCR)-negativity by combined treatment with all-trans-retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10233841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow

1 reference

https://pubmed.ncbi.nlm.nih.gov/10233841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of the RT-PCR assay of PML-RARA transcripts in acute promyelocytic leukemia. The Leukemia Study Group of the Ministry of Health and Welfare (Kouseisho)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10233841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10233841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8; 21)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10233841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10233841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10233841

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S0002-9440(10)65355-2

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35786822&oldid=1658504190"